Satellite Symposia

Sunday 15 June 2014

13:00 – 15:00

Satellite Symposium (Merck & Co.)

13:00 – 13:05

Welcome and Opening Remarks – O.A. Cornely (Germany)

13:05 – 13:30

Pharmacologic Principles and Clinical Evidence for the Management of Mucormycosis – D. Kontoyiannis (USA)

13:30 – 13:55

Therapeutic Drug Monitoring:  Necessary for Prophylaxis? – D. Sheppard (Canada)

13:55 – 14:20

Phase 1B Study of the Pharmacokinetics and Safety of Posaconazole Solid Oral Tablet in Patients at Risk for Invasive Fungal Infection (IFI) – R. Duarte (Spain)

14:20 – 14:45

Phase 3 Study of the Pharmacokinetics and Safety of Posaconazole Solid Oral Tablet in Patients at Risk for Invasive Fungal Infection (IFI) – O. Cornely (Germany)

14:45 – 14:55

Q&A – Faculty

14:55 – 15:00

Closing Remarks – O. Cornely (Germany)

16:30 – 18:30

Satellite Symposium organized by Pfizer Pharma

Management of Infections in the Immunocompromised Patient

Chair:  G. Maschmeyer (Berlin)

16:30 – 16:40

Welcome – G. Maschmeyer (Berlin)

16:40 – 17:05

Management of Infections with Multiresistant Pathogens in the Immunocompromised Patient – M. Deja (Berlin)

17:05 – 17:30

Azol Antifungals in High Risk Patients – C. Rieger (Munich)

17:30 – 17:55

Impact of Latent Virus Infections on the Clinical Course of SOT-Patients – P. Reinke (Berlin)

17:55 – 18:20

Vaccinations in Immunocompromised Patients – U. Baumann (Hannover)

18:20 – 18:30

Discussion, Closing Remarks – G. Maschmeyer (Berlin)

Monday 16 June 2014

12:30 – 14:00

Satellite Symposium organized by Astellas Pharma

Clinical Problem Solving in Transplant Patients and Immunocompromised Hosts

12:30 – 12:35

Introduction – J. M. Aguado (Madrid)

12:35 – 13:00

Liver Transplantation in the MELD era – Infection Risks, Prophylaxis, Trends – L. Fischer (Hamburg)

13:00 – 13:25

Clostridium difficile Infections (CDI) in Immunocompromised Patients – Minimizing Risks, Managing Consequences – O. Cornely (Koln)

13:25 – 13:50

Antifungal Prophylaxis – Facing the Challenges and Obstacles – J. Maertens (Leuven)

13:50 – 14:00

Wrap-up and Questions – J. M. Aguado (Madrid)



© International Immunocompromised Host Society
Powered by Wild Apricot Membership Software